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Objectives. International guidelines differ in the threshold of tuberculin skin test (TST) induration regarded as indicating
Mycobacterium (M.) tuberculosis infection. Interferon gamma release assay (IGRA) results were used as reference to assess
performance of TST induration thresholds for detection ofM. tuberculosis infection in children. Design. Systematic review which
included studies containing data on TST, IGRA, and Bacillus Calmette-Gue´rin (BCG) status in children. Data bases searched were
PubMed, EMBASE, and the Cochrane library. Specificities and sensitivities were calculated for TST thresholds 5, 10, and 15mm
and correlated with age and geographical latitude. Results. Eleven studies with 2796 children were included. For BCG immunised
children diameters of 5, 10, and 15mmhadmedian sensitivities of 87, 70, and 75% and specificities of 67, 93, and 90%, respectively. In
non-BCG immunised children median sensitivities were 94, 95, and 83% and specificities 91, 95, and 97%. At the 10mm threshold
age correlated negatively with sensitivity of TST (𝑟 = −0.65, 𝑃 = 0.04) and latitude correlated positively (𝑟 = 0.71, 𝑃 = 0.02).
Conclusions. For the 10mm threshold the sensitivity of the TST is lower in BCG immunised children. Younger age and higher
geographical latitude were associated with higher sensitivity of the TST.
1. Introduction
International guidelines differ in the threshold of tuber-
culin skin test (TST) induration regarded as indicating
Mycobacterium (M.) tuberculosis infection in children with
previous Bacillus Calmette-Gue´rin (BCG) immunisation.
In the UK this is 15mm and in the United States and
Spain 10mm [1]. The high risk posed by M. tuberculosis
for children less than two years of age, with a risk of
progression to disseminated tuberculosis and meningitis
from 10 to 20% and tuberculosis in general of 50%, makes
it essential to diagnose latent M. tuberculosis infection with
maximum sensitivity. There is no gold standard test available
to assess the sensitivity and specificity of tuberculin skin tests
(TST) against in latent M. tuberculosis infection. Interferon
gamma release assays (IGRA) have been shown to be more
specific than TST particularly in BCG immunised persons
[1] and may be more sensitive in children less than 2 years
old and in low income countries where malnutrition and
helminth and HIV infection are common [1–3]. Therefore
the better performance characteristics of the IGRA compared
to the TST make IGRA a suitable reference standard to
determine the threshold of TST induration diameter used
to define M. tuberculosis infection in children with and
without BCG immunisation. This investigation adopted the
methodology of a systematic review to address the following
objectives:
(1) to define the TST induration diameter with the best
sensitivity and specificity in diagnosingM. tuberculo-
sis infection compared to IGRA in children with and
without previous BCG immunisation;
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(2) to determine the false negative rate of the TST
with IGRA as reference standard for different TST
induration thresholds;
(3) to assess the age dependency of sensitivity and speci-
ficity of TST;
(4) to assess the dependency of sensitivity and specificity
of TST on geographical latitude.
2. Methods
2.1. Inclusion and Exclusion Criteria. Included were studies
containing data on TST, IGRA, and BCG status of each
participant in children (<16 years of age). Excluded were
studies not allowing extraction of data on TST, IGRA, and
BCG status in children or where results were only available
for mixed adults and children groups. Excluded were data on
patients with indeterminate IGRA.
2.2. Search Strategy. Data bases searched by the two authors
independently were MEDLINE and Premedline (PubMed),
EMBASE, and the Cochrane library using the key words:
ELISPOT, QuantiFERON, interferon gamma release assay,
IGRA, child, infant, newborn, neonate, and tuberculosis with
a limit to: Human and English Language and Publication
Year from 1993. Extracted were data on results for IGRA and
TST and BCG immunisation, type of IGRA, procedure of
TST, location of study, and proportion of children with active
tuberculosis, comorbidities, and age. Documentation of the
search strategy followed the PRISMA guidelines.
2.3. Data Analysis
2.3.1. Comparison of Sensitivities and Specificities for Different
Tuberculin Skin Test Induration Thresholds. Sensitivities and
specificities of TST induration thresholds measured against
IGRA result as reference standard were calculated from
individual patient data where it is possible using software
MedCalc Statistical Software 11.5.0 (MedCalc Software bvba,
Ostend, Belgium).
Medians for sensitivities and specificities across indura-
tion thresholds were compared by Kruskal-Wallis test to take
into account multiple comparisons. The Mann-Whitney 𝑈
test was used for comparison of specificities and sensitivities.
Parameters in patients with and without BCG immunisation
were compared by Fisher’s exact test where original data
were available. Because of the importance of not missing M.
tuberculosis infection in children the proportions of negative
TST with a positive IGRA were also calculated. For studies
which contained data for different induration thresholds for
the same population these were compared by Fisher’s exact
test.
2.3.2. Investigation of Inconsistency between Studies. Appro-
priate results were pooled in a meta-analysis to visualise
and calculate heterogeneity with a summary statistic derived
using the DerSimonian and Laird Random effects model
where significant heterogeneity was detected using Meta-
DISc 1.4 software (J. Zamora, V. Abraira, A.Muriel, KS. Khan,
Coomarasamy A. Meta-DiSc: a software for meta-analysis
of test accuracy data. BMC Medical Research Methodology
2006, 6:31).The 𝐼2 statistic was used to quantify inconsistency
(heterogeneity) of studies with 𝐼2 > 40%representingmoder-
ate, >60% substantial, and >80% considerable inconsistency.
Inconsistency (heterogeneity) of studies as documented in a
meta-analysis was explored by investigation of an association
of age, percentage of patients with active tuberculosis, and
geographical latitude with sensitivities and specificities. Geo-
graphical latitude was investigated because BCG immunisa-
tion is known to have a lower impact on the immune response
to tuberculin in areas closer to the equator. SPSS version 20
(SPSS Inc., Illinois, USA) was used to obtain correlations of
age, latitude, and rates of active tuberculosis and specificities
or sensitivities. Pearson’s correlation coefficient and Spear-
man’s rho were used for correlation analysis. Excel (Microsoft
Office Excel (Microsoft Corporation, Seattle, WA, USA))
was used to generate graphic representations of sensitivities
and specificities of different TST induration thresholds and
the correlation of sensitivities and specificities and age or
latitude. A𝑃 value of<0.05was taken to indicate a statistically
significant difference.
3. Results
3.1. Comparison of Sensitivities and Specificities for Different
Tuberculin Skin Test Induration Thresholds. There were 245
records identified from PubMed, 196 in EMBASE, and 7 in
the Cochrane library. 88 articles were retrieved for full text
review and a total of 234 records were excluded (see Figure 1:
PRISMA FLOW DIAGRAM). The 11 studies included had
usable data on 2796 children (see Table 1). All studies investi-
gated children as part of testing forM. tuberculosis infection.
All but one study [4] used two tuberculin units of PPD
RT 23 (Statens Serum Institute, Copenhagen, Denmark) for
conduction of the tuberculin skin test. Eight studies used the
QuantiFERON as IGRA, while three studies [1, 7, 13] used the
ELISPOT version. Sensitivities, specificities, and percentages
of false negative TST results for different TST induration
thresholds were tabulated in Table 2.
In BCG immunised children 5, 10, and 15mm induration
thresholds had median (range) sensitivities of 87 (74.6 to
100.0), 70 (25 to 87), and 75 (60.9 to 83.6) %, respectively, and
specificities of 67 (60.7 to 92.5), 93 (74.9 to 97.4), and 90 (70.7
to 97.0) %, respectively. In non-BCG immunised children
median sensitivities were 94 (89 to 100), 95 (84 to 100), and
83.6% (one study only), respectively, and specificities were
91 (88.9 to 92.5), 95 (95 to 100), and 97% (one study only),
respectively. There was no significant difference between
sensitivities (𝑃 = 0.43) or specificities (𝑃 = 0.13) of
induration thresholds with or without BCG immunisation
(see Figures 4 and 5).
Comparison of sensitivities of induration thresholds 5, 10,
and 15mm with or without previous BCG immunisation is
presented in Figure 4.There was no difference in sensitivities
for a 5 or 15mm induration threshold between patients
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245 records identified
from MEDLINE and pre-
medline
196 records identified
in EMBASE
7 records identified in
the Cochrane library
448 records identified
88 articles
identified for
full text review
77
articles
excluded
11 articles included
Review, comment, or guideline only: 42
No data on tuberculin skin test results or
BCG status in children with IGRA test: 150
No data on testing for mycobacterium
tuberculosis: 7
Mixed population of adults and children: 22
Only children with positive TST tested by
IGRA: 1
Case report only: 3
Hypothetical paper: 1
234 records excluded (157 at abstract and
77 at full text review):
203 duplicates
removed
PRISMA flow diagram
Figure 1: Study selection for systematic review—PRISMA flow diagram.
with and without BCG immunisation (𝑃 = 0.26 and 𝑃 =
0.50, resp.). For the 10mm induration threshold sensitivities
were significantly lower and hence false negative TST’s were
significantly more common (𝑃 = 0.014) in children with
BCG immunisation.
For this 10mm induration threshold very low sensitivities
were reported in one study from Uganda [13] (25%) and
one from South Africa [9] (33.3%). Analysis of the Ugandan
study’s anthropometric data showed a low level of under-
nutrition, with prevalence of wasting being 5.4%. 13 (1.4%)
of the participants were HIV infected, and the prevalence of
other infections was as follows: asymptomatic malaria 4.0%,
helminth infection 9.6%, and active tuberculosis 0.3%. In
the South African study [9] all children had cancer: 61.8%
haematological malignancies, 32.4% solid tumors, and 5.9%
others.
One study with low specificity [1] (59.7%) was conducted
in Istanbul, Turkey, with an ELISPOT, which was a precursor
of the currently commercially available ELISPOT version.
The other study showed a specificity of 60.8% [5] and was
conducted in Seoul, South Korea, and 59.3% were clini-
cally unwell with causes other than tuberculosis including
pneumonia, chronic cough, fever of unknown origin, and
lymphadenopathy.
3.2. Investigation of Inconsistency between Studies. For a
10mm induration threshold in BCG immunised children a
meta-analysis was employed to investigate for inconsistency
(heterogeneity) between study results (see Figures 2 and 3).
The studies Bakir 2009 and Mendez-Echevarria 2011 could
not be included in the meta-analyses because the reports
only allowed extraction of the sensitivities and specificities
and not the raw data from which they were calculated. For
other induration thresholds there were not enough studies
available to allow for a meaningful meta-analysis to explore
inconsistency between the majority of studies. The meta-
analysis revealed considerable inconsistency (heterogeneity)
of studies with regards to analysis of both sensitivities and
specificities (see Figures 2 and 3).
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Table 1: Characteristics of studies reporting on children with results on tuberculin skin test and interferon gamma release assay and
information on BCG immunisation status (TB: tuberculosis).
Study reference Country Setting Reason fortesting Age
Children with BCG
immunisation
Children without
BCG
immunisation
Active TB
(%)
Dogra et al.
2007 [4]a India
Rural Medical
School
Suspect cases or
contacts
Median: 6.0
years (range 1 to
12)
86 19 10.5
Chun et al. 2008
[5] South Korea
Municipal
Children’s
Hospital
Close and casual
contacts and
cases
Median 3.2 years
(range 0–15.8) 145 — 3.0
Taylor et al.
2008 [6]
United
Kingdom
Municipal
Hospital Contacts
Mean 10 years
(range 4 to 16) 45 —
10.9
(suspected)
Nicol et al. 2009
[7] South Africa
Semirural
population
Suspected
tuberculosis or
contacts
Median 1.5 years
(IQR 1.1 to 2) 214 — 26.8
Bakir et al. 2009
[1] Turkey
Municipal
clinics Contacts
Median 7 years
(IQR 3 to 11) 652 209 1.3
Soon et al. 2010
[8] South Korea
Municipal
Hospital Contacts Median 5 years 26 — 21.2
Stefan et al. 2010
[9] South Africa
Municipal
Hospital
Children newly
diagnosed with
cancer
Median 7 years
(range 0.1 to 15) 29 — 2.9
Me´ndez-
Echevarr´ıa et al.
2011 [10]
Spain MunicipalHospitals
Immigrants
from endemic
areas, contacts,
and cases
Mean age 4.73
(range 0.1 to 15) 213 246 14.8
Kasambira et al.
2011 [11] South Africa
Rural clinics,
District Hospital Contacts
Median age 6
years (IQR 3 to
9)
236 — 19.0
Moyo et al. 2011
[12] South Africa Rural district
Contacts and
suspected cases
Median 1.9 years
(range 0.75 to
2.83)
376 — 13.1
Nkurunungi et
al. 2012 [13] Uganda
Municipal
Hospital
Population
based screening 5 years 300 — 0.3
aNumbers in brackets refer to the number of the reference in References of the paper.
We therefore explored potential sources of such inconsis-
tency like presence of active tuberculosis, age, and geograph-
ical latitude.
The percentage of M. tuberculosis infected patients with
features of active pulmonary tuberculosis did not correlate
with sensitivity or specificity of the 10mm threshold (𝑃 >
0.10).
Correlation analysis of sensitivity and age (Figure 6) or
geographical latitude (Figure 7) was conducted for a sub-
group of studies with data on an induration threshold of
10mm and previous BCG immunisation. This subgroup was
chosen as it was the only group with sufficient numbers to
allow such an analysis.
Correlation of TST sensitivity with age (using an indura-
tion threshold of 10mm) revealed a Spearman’s rho corre-
lation coefficient of −0.65 (𝑃 = 0.04) (Figure 6) indicating
increased sensitivity of tuberculin skin testing relative to
IGRA in younger children. Correlation of sensitivities with
geographical latitude revealed a Pearson correlation coeffi-
cient of 0.71 (𝑃 = 0.02) indicating increased sensitivity of
tuberculin skin testing with higher latitude (Figure 7).
Specificities for a threshold of 10mm were equal or
above 75% for all studies. There was no significant change in
specificity at different ages or latitude.
3.3. Comparison of Sensitivity and Specificity of TST Indura-
tion Thresholds in BCG versus Not BCG Immunised Children.
Three studies contained original data or results of analyses on
children both with and without BCG immunisation.
The first [4] allowed direct statistical comparison of
sensitivities and specificities in BCG immunised versus not
immunised children. For a 10mm induration threshold
sensitivity in BCG immunised children was 62.5% (95%
CI 24.49 to 91.48) and in nonimmunised children 100.0%
(95% CI 29.24 to 100.0) (𝑃 = 0.49). Specificity was also
not significantly different between those immunised: 97.44%
(95%CI 91.04 to 99.69) and those not immunised: 100% (95%
CI 79.41 to 100.0) (𝑃 = 0.90).
The second study by Bakir et al. [1] demonstrated at a TST
induration threshold of 10mm a sensitivity of 81.8% (95% CI
76.5 to 86.4) in BCG immunised people similar to 84.5% (95%
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Table 2: Sensitivities and specificities of tuberculin skin test thresholds and BCG immunisation status.
Study reference
BCG immunisation
status (immunised +,
not immunised −)
Sensitivity (95%
confidence interval)
Specificity (95%
confidence interval)
False negative rate as
percentage (95% confidence
interval) of people with
negative tuberculin skin
test amongst IGRA positive
patients
TST induration threshold 5mm
Chun et al. 2008 [5]a + 86.7 (59.5 to 98.3) 60.8 (51.8 to 69.2) 13.3 (1.7 to 40.5)
Bakir et al. 2009 [1] + 87.4 (82.6 to 91.2) 59.7 (54.7 to 64.5) 12.6 (8.8 to 17.4)
− 89.1 (81.7 to 94.2) 88.9 (81.0 to 94.3) 10.9 (5.8 to 18.3)
Soon et al. 2010 [8] + 100.0 (54.1 to 100.0) 75.00 (50.9 to 91.3) 0.0 (0.0 to 45.9)
Me´ndez-Echevarr´ıa et al. 2011 [10] − 100.0 (95.0 to 100.0) 93.6 ( 88.7 to 96.5) 0.0 (0.0 to 5.0)
Kasambira et al. 2011 [11] + 74.7 (63.3 to 84.0) 92.5 (87.3 to 96.1) 25.3 (16.0 to 36.7)
TST induration threshold 10mm
Dogra et al. 2007 [4] + 62.5 (24.5 to 91.5) 97.4 (91.0 to 99.7) 37.5 (8.5 to 75.5)
− 100.0 (29.2 to 100.0) 100.0 (79.4 to 100.0) 0.0 (0.0 to 70.8)
Chun et al. 2008 [5] + 73.3 (44.9 to 92.2) 81.5 (73.8 to 87.8) 26.6 (7.8 to 55.1)
Bakir et al. 2009 [1] + 81.8 (76.5 to 86.4) 74.9 (70.4 to 79.1) 18.2 (13.6 to 23.5)
− 84.5 (76.4 to 90.7) 91.9 (84.7 to 96.4) 15.5 (9.3 to 23.6)
Nicol et al. 2009 [7] + 87.0 (75.1 to 94.6) 77.5 (70.2 to 83.7) 13.0 (5.4 to 24.9)
Soon et al. 2010 [8] + 66.7 (22.3 to 95.7) 95.0 (75.1 to 99.8) 33.3 (4.3 to 77.7)
Stefan et al. 2010 [9] + 33.3 (0.008 to 90.6) 92.3 (74.9 to 99.0) 66.6 (9.4 to 99.2)
Kasambira et al. 2011 [11] + 64.0 (52.1 to 74.8) 95.6 (91.2 to 98.2) 36.0 (25.2 to 47.9)
Me´ndez-Echevarr´ıa et al. 2011 [10] + 82.6 (63.0 to 93.0) 86.0 (80.0 to 90.0) 17.4 (7.0 to 37.0)
− 95.9 (88.6 to 98.6) 95.5 (91.1 to 97.8) 4.1 (1.4 to 11.4)
Moyo et al. 2011 [12] + 83.8 (72.9 to 91.6) 95.8 (92.9 to 97.7) 16.1 (8.4 to 27.1)
Nkurunungi et al. 2012 [13] + 25.0 (15.3 to 36.9) 97.4 (94.5 to 99.0) 75.0 (63.1 to 84.7)
TST induration threshold 15mm
Taylor et al. 2008 [6] + 75.0 (19.4 to 99.4) 70.7 (54.5 to 83.9) 25.0 (0.6 to 80.6)
Bakir et al. 2009 [1] + 75.5 (69.7 to 80.7) 90.5 (87.2 to 93.2) 24.5 (19.3 to 30.3)
− 83.6 (75.4 to 90.0) 97.0 (91.4 to 99.4) 16.4 (10.0 to 24.6)
Me´ndez-Echevarr´ıa et al. 2011 [10] + 60.9 (40.8 to 77.8) 97.0 (92.4 to 98.2) 39.1 (22.2 to 59.2)
aNumbers refer to the number of the reference in References of the paper.
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Figure 2: Meta-analysis of sensitivity of a 10mm induration threshold of a tuberculin skin test in BCG immunised children (DerSimonian
and Laird random effects model).
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Figure 3: Meta-analysis of specificity of a 10mm induration threshold of a tuberculin skin test in BCG immunized children (DerSimonian
and Laird random effects model).
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Figure 4: Sensitivity of different tuberculin skin test thresholds for
detection ofM. tuberculosis infection with (diamonds) and without
(bullets) previous BCG immunisation with IGRA as a reference
standard (each dot represents the result of one study).
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Figure 5: Specificity of different tuberculin skin test thresholds for
detection ofM. tuberculosis infection with (diamonds) and without
(bullets) previous BCG immunisation with IGRA as a reference
standard (each dots represents the result of one study).
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Figure 6: Sensitivity of a 10mm threshold of induration of tuber-
culin skin test for detection of M. tuberculosis infection in relation
to age in BCG immunised children using interferon gamma release
assay as reference standard.
CI 76.4 to 90.7) in nonimmunised children. Specificity was
significantly lower: 74.9% (95%CI 70.4 to 79.1) in immunised
compared to nonimmunised children 91.9% (95% CI 84.7 to
96.4).
In the third study by Me´ndez-Echevarr´ıa et al. [10]
sensitivity was 82.6% (95% CI 63 to 93) in BCG immunised
people compared to 95.9% (95% CI 88.6 to 98.6) in non-
immunised people and specificity was 86% (95% CI 80 to
90) in immunised people was significantly lower than in
nonimmunised people with 95.5% (95% CI 91.1 to 97.8).
3.4. Comparison of False Negative TST Results with Different
TST Induration Thresholds. In BCG immunised children 5,
10 and 15mm induration thresholds had median (range)
false negative rates of 13 (0.0 to 25.4), 30 (13 to 76), and
25 (16.4 to 39.1)%, respectively. In non-BCG immunised
children median false negative rates were 6 (0.0 to 11), 5
(0.0 to 16), and 16.4%, respectively. There was no significant
difference between false negative rates (𝑃 = 0.43) comparing
different induration thresholds. The result was the same with
or without BCG immunisation. For the 10mm induration
Tuberculosis Research and Treatment 7
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Figure 7: Correlation of sensitivity of a 10mm tuberculin skin test
induration threshold in BCG immunised childrenwith geographical
latitude of location where studies were conducted: each diamond
shaped marker allocates a geographical latitude of the town where
the study was located to the sensitivity of the 10mm induration
threshold for studies [1, 4, 5, 7–13].
threshold the false negative rate was significantly higher in
BCG immunised versus non-BCG immunised children (𝑃 =
0.014).
Two studies [5, 11] allowed comparisons of sensitivities
and the corresponding false negative TST rates (Table 2)
within the same study. For Chun et al. [5] these were not
significantly different between TST induration thresholds of
5 and 10mm (𝑃 = 0.65). For the study by Kasambira et
al. [11] there was also no significant difference in sensitivity
and the corresponding false negative TST rates between these
induration thresholds (𝑃 = 0.21).
4. Discussion
4.1. Comparing Parameters Determining Diagnostic Accuracy
between Induration Thresholds. This investigation showed
that there were no significant differences in sensitivities or
specificities between TST induration thresholds of 5, 10, or
15mm or children with and without BCG immunization,
but the number of studies was too small and they were too
heterogenous to exclude a clinically significant difference.
For the 10mm threshold BCG immunised children had a
lower sensitivity of the TST compared to non-immunized
children, which may be due to comorbidities in the South
African study [9] (oncology patients) and coinfections in the
Ugandan study [13] affecting the TST more than the IGRA.
Future studies should investigate whether TST induration
threshold should be lower in BCG immunised children to
optimise sensitivity.
4.2. The Significance of a False Negative Tuberculin Skin Test.
The better correlation of IGRA versus TST with exposure in
previous contact investigations particularly in BCG immu-
nised populations was reflection of a higher specificity of
IGRA compared to TST. It is thus not the rate of negative
IGRA results amongst positive TST results which is clinically
relevant but the rate of negative TST results amongst patients
with positive IGRA. This latter rate is not likely to represent
false positive IGRA results but indicates lower sensitivity
of the TST. In view of the increased risk of progression to
potentially fatal tuberculous meningitis in children less than
two years old the 13 and 16% false negative TST rates at a
10mm induration in BCG immunised populations with a
median age of less than two years of this review [7, 12] suggest
that both TST and IGRA should be used simultaneously
to investigate M. tuberculosis infection if this threshold is
used to define TST positivity. A subgroup analysis contained
in another of the included studies [1] which did not break
down the results according to BCG vaccination status was
derived from 32 less than 2-year-old children and found false
negative rates for a 5mm TST induration threshold of 21.9%,
for a 10mm threshold 34.4%, and for a 15mm threshold
37.5%. Application of an induration threshold of 15mm for
definition of a positive TST in people with previous BCG
immunisation was associated with an unacceptably high rate
of false negative TST from 24 to 39% in the studies reviewed.
4.3. Investigation of Causes of Inconsistency. Higher geo-
graphical latitude was associated with higher sensitivity of
the tuberculin skin test in BCG immunised children. This
may be due to the fact that BCG immunisation is associated
with a reduced effect on the Th1 response to tuberculin at
lower latitudes [14, 15]. This may explain the low sensitivity
in the Ugandan study. Causes for this observation may
include a Th2 dominated immune response associated with
helminth infections or concomitant malnutrition reducing a
Th1 dominated delayed hypersensitivity reaction. Increased
sensitivities of the 10mm TST threshold with younger age
with the highest between 80 and 90% in children between one
and two years of age may indicate that there is no reduction
of TST sensitivity in younger children.
4.4. Implications for Clinical Practice and Future Research.
The use of 5 and 15mm induration thresholds in TSTs in
guidelines for testing of young children for M. tuberculosis
infection is currently not evidence based. The literature
search did not find studies exclusively conducted on infants.
The studies available for this review did not contain data on
a 5mm or 15mm induration threshold for less than two-
year-old children but because of the high risk associated with
missing M. tuberculosis infection an induration threshold of
15mm should not be used in children <2 years of age. IGRA
testing should not be reserved for confirmatory testing in
children less than two years of age for any TST induration
threshold.
Future studies need to assess sensitivities of TST thresh-
olds for infants measured against IGRA results and need to
investigate systematically the influence of systemic inflam-
matory response syndromes associated with nontuberculous
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infections and haematological malignancies on the sensi-
tivity of TST compared to IGRA. The influence of BCG
immunisation on TST specificity needs to be investigated
for all induration thresholds to determine which threshold
optimises specificity without compromising sensitivity for all
age groups.
5. Conclusions
For the 10mm threshold there was a lower sensitivity of the
TST in BCG immunised children.
Younger age and higher latitude were associated with
higher sensitivity of the tuberculin skin test.
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